News

HHS Gets Tough With Six Drugmakers Over Noncompliance With 340B Program; Companies Push Back

By | Drug Industry Daily | No Comments

The Health Resources and Services Administration (HRSA) has sent letters to six pharmaceutical companies — AstraZeneca, Eli Lilly, Novartis, Novo Nordisk, Sanofi, and United Therapeutics — letting them know their failure to comply with the 340B drug discount program has been referred to the Office of Inspector General at HHS. And several of the companies are pushing back.
Source: Drug Industry Daily

CDC Panel Recommends COVID-19 Boosters for Some, But Not for Those at Risk in the Workplace

By | Drug Industry Daily | No Comments

A Centers for Disease Control and Prevention (CDC) expert panel yesterday voted 9 to 6 that people aged 18-49 with underlying health conditions should be eligible to receive a booster vaccine, but voted down, 6 to 9, recommending a booster shot for people in that age group at risk of contracting the coronavirus based on their workplace.
Source: Drug Industry Daily